Dr. Marty Makary, the agency’s commissioner, has said too many women avoid menopause treatments because the risks have been ...

FDA Commissioner Marty Makary, whose agency convened a panel of experts earlier in the day to discuss the topic, told ...

US Food and Drug Administration Commissioner Marty Makary signaled Thursday that he is open to revising strict warning labels ...

The culture of academic medicine needs to change, FDA Commissioner Marty Makary, MD, MPH, said at an event sponsored by The ...

Hormone therapy has endured a rather bumpy history after the Women’s Health Initiative published clinical trial data in 2002 ...

The FDA is reevaluating longtime warnings on hormone replacement therapy products for menopausal women. Some advocates for ...

For decades, proponents of psychedelic drugs have come to Washington with a provocative message: Illegal, mind-altering ...

The FDA is reevaluating longtime warnings on hormone replacement therapy products for menopausal women. Some advocates for change say the so-called “black box” that lists health risks is discouraging ...

During a press conference on Monday, Food and Drug Administration Commissioner Marty Makary spoke about the agency's ...

Nearly six months into President Trump’s second term, The Hill and NewsNation team up to host the inaugural Hill Nation ...

The US could scrap warnings on hormone replacement therapy (HRT) in a major shake-up of the treatment for menopause.

According to Makary, reducing user fees—which make up just under half of the FDA's budget—could make it easier for smaller ...